Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pericapsular ropivacaine for pain reduction after hip arthroscopy
ACTRN12611000714987Phase 4Not yet recruiting
- Sponsor
- The University of Auckland
- Start
- Nov 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by The University of Auckland. Primary endpoint: Postoperative pain score reduction. Planned start Nov 2011; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12611000714987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000714987.